Report Detail

Pharma & Healthcare Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review

  • RnM2733696
  • |
  • 07 January, 2019
  • |
  • Global
  • |
  • 32 Pages
  • |
  • GlobalData
  • |
  • Pharma & Healthcare

Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sinphar Pharmaceutical Co Ltd (Sinphar) is a healthcare company that carries out the development, manufacture and sale of pharmaceutical drugs, healthy foods and cosmetics. The company’s pharmaceutical product portfolio includes antifungal agents, anti-hypersensitive agents, cardiovascular agents, dermatologic agents, ophthalmic agents, skincare products, health supplements and others. It also has several products in pipeline addressing dementia, dry age-related macular degeneration, triple-negative breast cancer, pancreatic cancer, genital warts and others. Sinphar also offers contract manufacturing services to pharmaceutical companies for the development of new products. It has presence in China, Taiwan, Canada and other countries. Sinphar is headquartered in Tungshan, Yilan, Taiwan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Table of Contents

    Table of Contents 3

      List of Tables 4

        List of Figures 4

          Section 1 - About the Company 5

            Sinphar Pharmaceutical Co Ltd - Key Facts 5

              Sinphar Pharmaceutical Co Ltd - Key Employees 6

                Sinphar Pharmaceutical Co Ltd - Key Employee Biographies 7

                  Sinphar Pharmaceutical Co Ltd - Major Products and Services 8

                    Sinphar Pharmaceutical Co Ltd - History 9

                      Sinphar Pharmaceutical Co Ltd - Locations And Subsidiaries 10

                        Head Office 10

                          Other Locations & Subsidiaries 10

                            Section 2 – Company Analysis 11

                              Company Overview 11

                                Sinphar Pharmaceutical Co Ltd - Business Description 12

                                  Sinphar Pharmaceutical Co Ltd - SWOT Analysis 13

                                    SWOT Analysis - Overview 13

                                      Sinphar Pharmaceutical Co Ltd - Strengths 13

                                        Sinphar Pharmaceutical Co Ltd - Weaknesses 14

                                          Sinphar Pharmaceutical Co Ltd - Opportunities 15

                                            Sinphar Pharmaceutical Co Ltd - Threats 16

                                              Sinphar Pharmaceutical Co Ltd - Key Competitors 17

                                                Section 3 – Company Financial Ratios 18

                                                  Financial Ratios - Capital Market Ratios 18

                                                    Financial Ratios - Annual Ratios 19

                                                      Performance Chart 22

                                                        Financial Performance 22

                                                          Financial Ratios - Interim Ratios 23

                                                            Financial Ratios - Ratio Charts 24

                                                              Section 4 – Company’s Lifesciences Financial Deals and Alliances 25

                                                                Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

                                                                  Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26

                                                                    Sinphar Pharmaceutical Co Ltd, Recent Deals Summary 27

                                                                      Section 5 – Appendix 28

                                                                        Methodology 28

                                                                          Ratio Definitions 28

                                                                            About GlobalData 32

                                                                              Contact Us 32

                                                                                Disclaimer 32

                                                                                Summary:
                                                                                Get latest Market Research Reports on Sinphar Pharmaceutical Co Ltd (1734). Industry analysis & Market Report on Sinphar Pharmaceutical Co Ltd (1734) is a syndicated market report, published as Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review. It is complete Research Study and Industry Analysis of Sinphar Pharmaceutical Co Ltd (1734) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                Last updated on

                                                                                REPORT YOU MIGHT BE INTERESTED

                                                                                Purchase this Report

                                                                                $500.00
                                                                                $250.00
                                                                                $1,000.00
                                                                                $1,500.00
                                                                                399.00
                                                                                199.50
                                                                                798.00
                                                                                1,197.00
                                                                                467.00
                                                                                233.50
                                                                                934.00
                                                                                1,401.00
                                                                                78,135.00
                                                                                39,067.50
                                                                                156,270.00
                                                                                234,405.00
                                                                                41,745.00
                                                                                20,872.50
                                                                                83,490.00
                                                                                125,235.00
                                                                                Credit card Logo

                                                                                Related Reports


                                                                                Reason to Buy

                                                                                Request for Sample of this report